A federal judge denied Florida Blue's request to reconsider Medicare Advantage star ratings linked to Broward County's 2023 flooding, citing CMS's regulatory criteria for public health emergencies.
Explore how private equity's rise in U.S. health care consolidation affects hospitals, physician practices, care quality, costs, and regulatory responses.
UnitedHealth Group's 2025 stock decline reflects rising medical costs and DOJ investigations, impacting healthcare sector valuations and Dow index dynamics.
Comprehensive update on critical U.S. healthcare and insurance issues including Medicaid policy, rural hospital challenges, Medicare Advantage scrutiny, FDA drug approvals, and public health dynamics.
UnitedHealth Group reports higher medical loss ratio and earnings challenges in Medicare Advantage, signaling a strategic shift amid rising care costs and regulatory scrutiny.
Optum is creating AI-driven risk coding to improve Medicare patient assessments, coinciding with DOJ investigations into Medicare Advantage practices by UnitedHealth Group.
UnitedHealth Group is reportedly under a DOJ criminal investigation for Medicare fraud, adding to existing probes amid leadership and financial outlook shifts.
Analysis of inflation rebate implementation under the Inflation Reduction Act highlights the need to include Medicare Advantage enrollees to maximize drug cost savings and deter pharmaceutical price hikes.
UnitedHealth Group raises 2025 medical cost projections and appoints Stephen Hemsley as CEO amid rising patient utilization and financial outlook withdrawal.
Insightful analysis of Medicare Advantage Plans highlights comprehensive coverage and positive policyholder experiences following the UHC CEO's death, focusing on insurance market realities and healthcare access.
